Indoleamine 2,3-dioxygenase in melanoma progression and BRAF inhibitor resistance.

Pharmacological Research : the Official Journal of the Italian Pharmacological Society
Silvana SandriSilvya Stuchi Maria-Engler

Abstract

Indoleamine 2,3-dioxygenase (IDO) is associated with the progression of many types of tumors, including melanoma. However, there is limited information about IDO modulation on tumor cell itself and the effect of BRAF inhibitor (BRAFi) treatment and resistance. Herein, IDO expression was analyzed in different stages of melanoma development and progression linked to BRAFi resistance. IDO expression was increased in primary and metastatic melanomas from patients' biopsies, especially in the immune cells infiltrate. Using a bioinformatics approach, we also identified an increase in the IDO mRNA in the vertical growth and metastatic phases of melanoma. Using in silico analyses, we found that IDO mRNA was increased in BRAFi resistance. In an in vitro model, IDO expression and activity induced by interferon-gamma (IFNγ) in sensitive melanoma cells was decreased by BRAFi treatment. However, cells that became resistant to BRAFi presented random IDO expression levels. Also, we identified that treatment with the IDO inhibitor, 1-methyltryptophan (1-MT), was able to reduce clonogenicity for parental and BRAFi-resistant cells. In conclusion, our results support the hypothesis that the decreased IDO expression in tumor cells is one of the ma...Continue Reading

References

Oct 18, 2003·Laboratory Investigation; a Journal of Technical Methods and Pathology·Jeffrey R LeeDavid H Munn
Jan 15, 2004·Trends in Molecular Medicine·David H Munn, Andrew L Mellor
Jun 28, 2006·The Journal of Experimental Medicine·Hidetoshi SumimotoYutaka Kawakami
May 4, 2007·The Journal of Clinical Investigation·Jeremy B Swann, Mark J Smyth
May 4, 2007·The Journal of Clinical Investigation·David H Munn, Andrew L Mellor
Jun 15, 2007·British Journal of Cancer·M E PolakI A Cree
Apr 17, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kazuhiko InoFumitaka Kikkawa
Jul 16, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Chantal Feder-MengusMaurizio Provenzano
Oct 2, 2009·International Journal of Cancer. Journal International Du Cancer·Maria ScatoliniGiovanna Chiorino
Feb 25, 2010·Clinical & Experimental Metastasis·Julia SchultzManfred Kunz
Aug 20, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Joshua D MezrichChristopher A Bradfield
Jun 7, 2011·The New England Journal of Medicine·Paul B ChapmanUNKNOWN BRIM-3 Study Group
Dec 14, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·James S WilmottRichard A Scolyer
Feb 24, 2012·The New England Journal of Medicine·Jeffrey A SosmanAntoni Ribas
Oct 26, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Xiaofeng JiangF Stephen Hodi
Jan 12, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Dennie T FrederickJennifer A Wargo
Mar 14, 2013·Oncoimmunology·Bishu SapkotaBrian P Pollack
Jun 12, 2013·The Journal of Experimental Medicine·Rikke B HolmgaardJames P Allison
Aug 30, 2013·Science Translational Medicine·Stefani SprangerThomas F Gajewski
Feb 22, 2014·Annual Review of Immunology·William M SchneiderCharles M Rice
May 9, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mohammad AtefiAntoni Ribas
Feb 4, 2016·Trends in Immunology·David H Munn, Andrew L Mellor
Jul 21, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Silvana SandriSilvya Stuchi Maria-Engler
Jul 28, 2017·Nature·Nikolaus FortelnyGabriela V Cohen Freue
Jan 15, 2018·Neoplasia : an International Journal for Oncology Research·Lukas KrähenbühlPhil F Cheng
May 22, 2018·Frontiers in Immunology·Flávia CastroMaria José Oliveira
Aug 3, 2018·Journal of Hematology & Oncology·Ming LiuYong Li
Sep 12, 2018·Seminars in Immunopathology·Alexander J MullerGeorge C Prendergast

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Jessica Godin-EthierRéjean Lapointe
BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
Sarah Yentz, David Smith
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
L BrochezV Krüse
© 2022 Meta ULC. All rights reserved